{"entity":{"type":"insider","cik":"0001291892","url":"/insider/0001291892","json_url":"/insider/0001291892.json","name":"Abingworth Management LTD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":8,"first":"2004-06-01","last":"2012-05-08","span_basis":"filed_date"},"name_variants":[{"name":"Abingworth Management LTD","source":"filing","n_filings":8,"first_seen":"2004-06-01","last_seen":"2012-05-08"}],"transactions":[{"id":2785710,"accession":"0001140361-12-023735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-12-023735","line_url":"/filing/0001140361-12-023735#line-2","is_derivative":false,"issuer_cik":"0001291892","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001291892","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100000.0,"shares_display":"1,100,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5500000.0,"total_display":"5,500,000.00","total_whole":"5,500,000","shares_owned_after":3600000.0,"shares_owned_after_display":"3,600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-04","filed_date":"2012-05-08","scope":"insider"},{"id":1645146,"accession":"0001181431-05-046917","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-05-046917","line_url":"/filing/0001181431-05-046917","is_derivative":false,"issuer_cik":"0001116449","issuer_name":"XENOGEN CORP","issuer_ticker":"XGEN","issuer_name_source":null,"issuer_url":"/issuer/0001116449","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1374571.0,"shares_display":"1,374,571","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":4000001.61,"total_display":"4,000,001.61","total_whole":"4,000,002","shares_owned_after":515464.0,"shares_owned_after_display":"515,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-08-11","filed_date":"2005-08-15","scope":"insider","n_lines":5},{"id":1497610,"accession":"0001332432-05-000005","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001332432-05-000005","line_url":"/filing/0001332432-05-000005","is_derivative":false,"issuer_cik":"0000913275","issuer_name":"Solexa, Inc.","issuer_ticker":"SLXA","issuer_name_source":null,"issuer_url":"/issuer/0000913275","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":829639.0,"shares_display":"829,639","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":3318556.0,"total_display":"3,318,556.00","total_whole":"3,318,556","shares_owned_after":1226769.0,"shares_owned_after_display":"1,226,769","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-07-12","filed_date":"2005-07-14","scope":"insider","n_lines":5},{"id":1585969,"accession":"0001291892-05-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001291892-05-000006","line_url":"/filing/0001291892-05-000006","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43163.0,"shares_display":"43,163","price_per_share":8.482,"price_display":"8.48","price_state":"stated","total_value":366108.566,"total_display":"366,108.57","total_whole":"366,109","shares_owned_after":873480.0,"shares_owned_after_display":"873,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-18","filed_date":"2005-01-20","scope":"insider","n_lines":4},{"id":1232015,"accession":"0001291892-05-000003","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001291892-05-000003","line_url":"/filing/0001291892-05-000003","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":46500.0,"total_display":"46,500.00","total_whole":"46,500","shares_owned_after":895148.0,"shares_owned_after_display":"895,148","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-12","filed_date":"2005-01-12","scope":"insider","n_lines":4},{"id":1231184,"accession":"0001291892-05-000003","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001291892-05-000003","line_url":"/filing/0001291892-05-000003","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":9.8525,"price_display":"9.85","price_state":"stated","total_value":197050.0,"total_display":"197,050.00","total_whole":"197,050","shares_owned_after":897658.0,"shares_owned_after_display":"897,658","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-11","filed_date":"2005-01-12","scope":"insider","n_lines":4},{"id":1231180,"accession":"0001291892-05-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001291892-05-000003","line_url":"/filing/0001291892-05-000003","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":9.866,"price_display":"9.87","price_state":"stated","total_value":739950.0,"total_display":"739,950.00","total_whole":"739,950","shares_owned_after":907698.0,"shares_owned_after_display":"907,698","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-10","filed_date":"2005-01-12","scope":"insider","n_lines":4},{"id":1326960,"accession":"0001072613-05-000041","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001072613-05-000041","line_url":"/filing/0001072613-05-000041","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":8.6975,"price_display":"8.70","price_state":"stated","total_value":869750.0,"total_display":"869,750.00","total_whole":"869,750","shares_owned_after":945348.0,"shares_owned_after_display":"945,348","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-06","filed_date":"2005-01-07","scope":"insider","n_lines":4},{"id":1326956,"accession":"0001072613-05-000041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001072613-05-000041","line_url":"/filing/0001072613-05-000041","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":8.0668,"price_display":"8.07","price_state":"stated","total_value":806680.0,"total_display":"806,680.00","total_whole":"806,680","shares_owned_after":995548.0,"shares_owned_after_display":"995,548","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-01-05","filed_date":"2005-01-07","scope":"insider","n_lines":4},{"id":9259494,"accession":"0001209191-05-014766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-014766","line_url":"/filing/0001209191-05-014766#line-1","is_derivative":false,"issuer_cik":"0001291892","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001291892","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130520.0,"shares_display":"130,520","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":783120.0,"total_display":"783,120.00","total_whole":"783,120","shares_owned_after":155367.0,"shares_owned_after_display":"155,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2005-03-10","scope":"insider"},{"id":278095,"accession":"0001209191-04-028932","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-04-028932","line_url":"/filing/0001209191-04-028932","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS INC","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001291892","owner_name":"Abingworth Management LTD","owner_display_name":"Abingworth Management LTD","owner_url":"/insider/0001291892","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":129480.0,"shares_display":"129,480","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":776880.0,"total_display":"776,880.00","total_whole":"776,880","shares_owned_after":94835.0,"shares_owned_after_display":"94,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-27","filed_date":"2004-06-01","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001356576","name":"SUPERNUS PHARMACEUTICALS INC","url":"/issuer/0001356576","role":"Ten percent owner","n_filings":1,"first_seen":"2012-05-08","last_seen":"2012-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001116449","name":"XENOGEN CORP","url":"/issuer/0001116449","role":"Ten percent owner","n_filings":1,"first_seen":"2005-08-15","last_seen":"2005-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000913275","name":"Solexa, Inc.","url":"/issuer/0000913275","role":"Ten percent owner","n_filings":1,"first_seen":"2005-07-14","last_seen":"2005-07-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Ten percent owner","n_filings":5,"first_seen":"2004-06-01","last_seen":"2005-03-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291892","retrieved_at":"2026-08-24T20:51:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}